Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
110.1 USD | +0.29% | +2.45% | +75.83% |
05-30 | Transcript : Natera, Inc. Presents at 2024 Leerink Partners Healthcare Crossroads Conference, May-30-2024 10:40 AM | |
05-23 | U.S. FDA advisers back approval for Guardant's cancer test | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+75.83% | 13.49B | |
+23.80% | 85.16B | |
-29.03% | 67.38B | |
-5.56% | 25.79B | |
+3.42% | 17.67B | |
-14.89% | 16.23B | |
+1.05% | 15.35B | |
+40.45% | 12.87B | |
+76.22% | 12.85B | |
-3.27% | 12.21B |
- Stock Market
- Equities
- NTRA Stock
- News Natera, Inc.
- Natera Says Federal Circuit Court of Appeals Upholds Invalidation of CareDx Patents